KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inovio Pharmaceuticals (INO) Exchange Rate Effect (2020 - 2024)

Historic Exchange Rate Effect for Inovio Pharmaceuticals (INO) over the last 11 years, with Q1 2024 value amounting to $32403.0.

  • Inovio Pharmaceuticals' Exchange Rate Effect rose 178941.61% to $32403.0 in Q1 2024 from the same period last year, while for Dec 2024 it was $32403.0, marking a year-over-year increase of 92660.71%. This contributed to the annual value of $32403.0 for FY2024, which is 92660.71% up from last year.
  • As of Q1 2024, Inovio Pharmaceuticals' Exchange Rate Effect stood at $32403.0, which was up 178941.61% from $483.0 recorded in Q4 2023.
  • Over the past 5 years, Inovio Pharmaceuticals' Exchange Rate Effect peaked at $32403.0 during Q1 2024, and registered a low of -$16563.0 during Q3 2022.
  • For the 5-year period, Inovio Pharmaceuticals' Exchange Rate Effect averaged around -$0.13, with its median value being -$1918.0 (2023).
  • In the last 5 years, Inovio Pharmaceuticals' Exchange Rate Effect crashed by 69665.05% in 2022 and then soared by 178941.61% in 2024.
  • Inovio Pharmaceuticals' Exchange Rate Effect (Quarter) stood at $21021.0 in 2020, then plummeted by 134.83% to -$7321.0 in 2021, then skyrocketed by 268.65% to $12347.0 in 2022, then plummeted by 96.09% to $483.0 in 2023, then surged by 6608.7% to $32403.0 in 2024.
  • Its Exchange Rate Effect was $32403.0 in Q1 2024, compared to $483.0 in Q4 2023 and -$2109.0 in Q3 2023.